Skip to main content

Table 2 Docking energy scores (Kcal/mol) for isolated compounds (1–4)

From: Phytochemical profile, comparative evaluation of Satureja montana alcoholic extract for antioxidants, anti-inflammatory and molecular docking studies

No

S

EMD

RMSD

E_conf

E_place

E_Int

E_vdw

Interaction

Bond type

Distance

E (Kcal/mol)

1VLK

 1

-4.66

-5.21

1.49

8.97

-93.34

-9.32

-23.14

GLY61

Ï€-Ï€

2.76

-0.5

 2

-6.13

-6.41

1.69

89.26

-112.64

-8.73

-23.67

GLY61

H-donor

2.90

-1.1

 3

-5.79

-6.52

1.33

58.30

-123.27

-10.42

-29.50

GLY58

H-donor

2.96

-0.9

TYR59

H-donor

3.03

-0.8

CYS62

H-acceptor

3.06

-2.4

 4

-5.89

-6.83

1.57

54.20

-63.46

-10.69

-33.65

PHE15

ASP13

H-donor

H-donor

2.88

2.94

-1.8

-1.6

1A3Q

 1

-6.15

-6.75

1.27

11.49

-111.71

-14.05

-35.09

Lys283

Ï€-Ï€

2.76

-0.5

 2

-2.49

-7.43

1.10

208.93

-122.80

-11.50

34.45

Lys283

Ï€-Ï€

2.90

-0.6

 3

-3.42

-8.12

1.62

157.69

-156.48

-11.90

26.80

Lys283

H-donor

2.96

-0.8

 4

-8.12

-8.80

1.21

57.64

-93.83

-16.24

-49.02

Ser70

H-donor

2.68

-0.5

2NVH

 1

-5.14

-6.42

1.29

8.68

-98.04

-12.88

-26.62

GLU25

PHE133

H-donor

H-Ï€

2.23

2.98

-1.4

-0.5

 2

-5.01

-6.80

1.01

77.53

-137.22

-10.60

-24.39

GLU25

LYS74

LYS77

H-donor

H-acceptor

H-acceptor

2.91

2.29

2.37

-2.7

-0.5

-0.7

 3

-5.43

-7.19

1.33

66.30

-148.91

-10.26

-25.28

GLU25

H-Ï€

2.23

-0.5

 4

-6.28

-7.57

1.18

57.01

-107.40

-10.28

-37.55

LYS74

ASP75

H-donor

H-acceptor

3.24

2.94

-0.5

-3

1CX2

 1

-5.89

-8.55

1.80

18.67

-28.93

-14.55

-23.26

TYR355

H-acceptor

3.73

-0.1

 2

-11.15

-8.67

1.01

235.79

-61.44

-10.15

29.09

ARG120

TYR355

H-acceptor

H-acceptor

2.72

2.82

-0.5

-2

 3

-12.20

-8.79

1.57

238.29

-47.70

-10.91

49.76

TYR355

H-acceptor

2.73

-1.1

 4

-10.41

-8.92

1.13

109.65

-17.23

-10.69

-8.35

Ser530

TYR355

H-donor

H-acceptor

2.93

2.7

-1.4

-1.8

Ref.1

-8.36

-8.25

1.16

89.13

-15.36

-8.65

-9.48

ARG120

H-acceptor

1.5

-2.69

1P9M

 1

-5.21

-7.48

1.86

20.29

-119.92

-4.69

-17.18

Arg168

H-acceptor

2.91

-2.5

 2

-6.41

-7.98

1.80

71.47

-121.35

-6.56

-34.99

Lys66

H-acceptor

2.14

-0.5

 3

-6.52

-8.47

1.04

55.47

-139.93

-5.97

-38.11

Cys192

Lys66

H-donor

H-acceptor

2.62

2.12

-0.7

-0.6

 4

-6.83

-8.97

1.46

55.56

-71.64

-1.62

-43.46

SER137

ALA58

PHE134

PHE134

H-donor

H-acceptor

H-Ï€

H-Ï€

3.52

3.9

4.15

-0.8

-0.5

-0.8

-0.7

  1. S; The ligand's final free binding energy from a particular posture, E conf; The ligand's free binding energy from a particular conformer. E place; The ligand's free binding energy from a receptor. E Int.: Ligand affinity binding energy with the receptor, Electrostatic interaction with the receptor, EeleVan der Waals energies between the ligand and the receptor are denoted by the abbreviation Evdw. RMSD is the root mean square deviation of the docking posture from the co-crystal ligand location. Ref.1:1-PHENYLSULFONAMIDE-3-TRIFLUOROMETHYL-5-PARABROMO PHENYLPYRAZOLE